Characterization of Early Response to Chronic Lung Injury using Chest CT
Characterization of Early Response to Chronic Lung Injury using Chest CT
批准号:
10079021
负责人:
Samuel Ash
金额:
$17.03万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-01-01 至 2023-12-31
关键词:
Advisory CommitteesAreaAwardChestChronicCicatrixClinicalCritical CareDensitometryDetectionDevelopmentDevelopment PlansDiseaseDisease ProgressionEarly identificationEducational workshopEvolutionFibrosisGoalsHospitalsImageImage AnalysisImaging TechniquesIndividualInflammationInflammatoryLaboratoriesLungLung diseasesMeasurementMeasuresMedical ImagingMedicineMentorsMentorshipMethodologyMethodsMinorityMonitorNational Heart, Lung, and Blood InstituteNetwork-basedOutcomePatientsPeripheralPharmaceutical PreparationsPredictive FactorPrimary PreventionPrincipal InvestigatorPublicationsPulmonary EmphysemaPulmonary FibrosisRadiologic FindingRadiology SpecialtyResearch PersonnelRiskRisk FactorsScanningScientistSensitivity and SpecificitySeverity of illnessSmokerSmokingStructure of parenchyma of lungSymptomsTeaching HospitalsTechniquesTissuesTrainingTraining ProgramsVisualWomanWorkX-Ray Computed Tomographyattenuationbasecareercareer developmentchest computed tomographycigarette smokingclinically relevantclinically significantconvolutional neural networkdeep learningdensitydisorder preventiondisorder riskexercise capacityfollow-upimprovedinterstitiallung injurymangemedical schoolsmodifiable riskmortalitynew technologynovelpalliatepalliating symptomspalliationpredictive modelingpreventprotein biomarkerspulmonary functionquantitative imagingrespiratoryresponseskillssmoking-related lung diseasestatistical and machine learningtobacco smoke exposuretooltreatment strategy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
In some individuals chronic tobacco smoke exposure results in emphysema and pulmonary fibrosis.
Both of these parenchymal changes are irreversible, highlighting the importance of the early identification of
their development and progression. Unfortunately, currently available methods for detecting the presence and
evolution of these changes have limited sensitivity and specificity for very early disease and for subtle disease
progression. Dr. Ash’s work has shown that automated objective analysis of computed tomography (CT)
scans of the chest can detect clinically relevant radiologic findings called interstitial changes that may
represent early pulmonary fibrosis, even in individuals without visually apparent disease. In the first aim of this
proposal, Dr. Ash will refine and utilize a more sensitive and specific automated CT analysis tool that he and
his lab have developed for the detection of both emphysema and interstitial changes. He will determine if
emphysema and interstitial changes detected using this method are clinically significant in those patients
deemed normal by previously performed visual analysis and in those deemed normal by other objective
approaches. In the second aim, he will determine if areas of locally high density tissue in visually normal
appearing lung parenchyma measured using augmented versions of his objective analysis tools are associated
with mortality, other clinical outcomes, and peripheral measures of inflammation. Finally, in the third aim he
will utilize these techniques to analyze longitudinal CT scans from the COPDGene study that were obtained
over 10 years of follow-up, and will identify factors that predict or modify the development and progression of
parenchymal changes on CT.
Dr. Ash will perform this work in the Division of Pulmonary and Critical Care Medicine at Brigham and
Women’s Hospital (BWH), a core teaching hospital of Harvard Medical School, under the mentorship of Dr.
George Washko, an expert in the field of medical image analysis and the co-principal investigator of the
Applied Chest Imaging Laboratory at BWH. With the guidance of Dr. Washko and his scientific advisory
committee, Dr. Ash has developed a comprehensive five year training program to develop the skills needed to
become an independent investigator with expertise in quantitative image analysis, including predictive
modeling and statistical machine learning.
Dr. Ash is dedicated to a career in academic medicine. His goal is to become a clinician-scientist using
the skills gained during this award to improve our ability to detect and monitor smoking related lung disease.
The techniques he has proposed may help identify modifiable risk factors and treatments for smoking related
lung disease, determine which patients are likely to benefit from treatment, and monitor the response to
therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterization of Early Response to Chronic Lung Injury using Chest CT
-
批准号:10320916
-
项目类别:
-
资助金额:$17.03万
-
财政年份:2019
-
负责人:Samuel Ash
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: